Fever and hypothermia in systemic inflammation: Recent discoveries and revisions

Frontiers in Bioscience

Volumn 10, Issue SUPPL. 1, 2005, Pages 2193-2216

  Romanovsky, Andrej A ^a   Almeida, Maria C ^a   Aronoff, David M ^b   Ivanov, Andrei I ^c   Konsman, Jan P ^d   Steiner, Alexandre A ^a   Turek, Victoria F ^e  

^a ST JOSEPH'S HOSPITAL AND MEDICAL CENTER   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^c EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d INSTITUT FRANÇOIS MAGENDIE   (France)

^e OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

Anapyrexia; Balance point; Blood brain barrier; Body temperature; Cytokines; Febrile response; Fever; Hypothermic response; IL 1beta; IL 6; Leptin; Lipopolysaccharide; LPS; PGE2; Prostaglandins; Set point; Thermoregulation; TNF alpha; Toll like receptors

Indexed keywords

ALPHA INTERMEDIN; ANGIOTENSIN; ANTIPYRETIC AGENT; ARGIPRESSIN; BACTERIUM LIPOPOLYSACCHARIDE; BLOOD CLOTTING FACTOR 5A; CELECOXIB; CHOLECYSTOKININ; COMPLEMENT COMPONENT C5; CORTICOTROPIN RELEASING FACTOR; CYCLOOXYGENASE 2 INHIBITOR; CYTOKINE; ENDOTOXIN; ENZYME; ICOSANOID; INTERLEUKIN 1; INTERLEUKIN 6; INTERLEUKIN DERIVATIVE; LEPTIN; LIPOPOLYSACCHARIDE; NEUROPEPTIDE; NEUROPEPTIDE Y; NONSTEROID ANTIINFLAMMATORY AGENT; OREXIN; PARACETAMOL; PEPTIDE; PEPTIDE HORMONE; PHOSPHOLIPASE; PROSTAGLANDIN; PROSTAGLANDIN E2; PROTEIN; PYROGEN; RECEPTOR; RECOMBINANT ANTIBODY; ROFECOXIB; THROMBOCYTE ACTIVATING FACTOR; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR ALPHA; UROCORTIN; VALDECOXIB;

ANALGESIC ACTIVITY; ANIMAL MODEL; ANTIPYRETIC ACTIVITY; BLOOD BRAIN BARRIER; BODY TEMPERATURE; BRAIN; BROWN ADIPOSE TISSUE; BULLET; CARDIOTOXICITY; CATABOLISM; CLINICAL PRACTICE; CONSENSUS; DRUG EFFICACY; DRUG SAFETY; FEVER; GASTROINTESTINAL TOXICITY; GENE; GENETIC MANIPULATION; HEART INFARCTION; HUMAN; HYPOTHERMIA; INFLAMMATION; MAGIC; MEDIATOR; MOUSE; NEPHROTOXICITY; NERVE CELL; NEW SPECIES; NONHUMAN; RAT; REVIEW; SIDE EFFECT; SIGNAL TRANSDUCTION; SKIN; STROKE; SYMPATHETIC NERVE CELL; SYNTHESIS; THERAPY; THERMOGENESIS; THERMOREGULATION; TRANSDUCER; VASOCONSTRICTION;

ANIMALIA; TERMINALIS;

EID: 21344444154     PISSN: 27686701     EISSN: 27686698     Source Type: Journal    
DOI: 10.2741/1690     Document Type: Review

References (235)

1. Schiltz J. C. & P. E. Sawchenko: Signaling the brain in systemic inflammation: the role of perivascular cells. Front Biosci 8, 1321-1329 (2003)
2. Steiner A. A. & L. G. S. Branco: Fever and anapyrexia in systemic inflammation: intracellular signaling by cyclic nucleotides. Front Biosci 8, s1398-s1408 (2003)
3. Blatteis C. M, S. Li, Z. Li, V. Perlik & C. Feleder: Signaling the brain in systemic inflammation: the role of complement. Front Biosci 9, 915-931 (2004)
4. Botting R: Antipyretic therapy. Front Biosci 9, 956-966 (2004)
5. Conti B, I. Tabarean, C. Andrei & T. Bartfai: Cytokines and fever. Front Biosci 9, 1433-1449 (2004)
6. Gourine A. V, N. Dale, V. N. Gourine & K. M. Spyer: Fever in systemic inflammation: roles of purines. Front Biosci 9, 1011-1022 (2004)
7. Leon L. R: Hypothermia in systemic inflammation: role of cytokines. Front Biosci 9, 1877-1888 (2004)
8. Mackowiak P. A: The febrile patient: diagnostic, prognostic, and therapeutic considerations. Front Biosci 9, 2297-2301 (2004)
9. Matsumura K. & S. Kobayashi: Signaling the brain in inflammation: the role of endothelial cells. Front Biosci 9, 2819-2826 (2004)
10. 2 as a mediator of fever: synthesis and catabolism. Front Biosci 9, 1977-1993 (2004)
11. Janský L. & S. Vybíral: Thermal homeostasis in systemic inflammation: modulation of neuronal mechanisms. Front Biosci 9, 3068-3084 (2004)
12. Kozak W. & V. Fraifeld: Non-prostaglandin eicosanoids in fever and anapyrexia. Front Biosci 9, 3339-3355 (2004)
13. 2 as a mediator of fever: the role of prostaglandin E (EP) receptors. Front Biosci 9, 3046-3057 (2004)
14. Romanovsky A. A: Signaling the brain in the early sickness syndrome: are sensory nerves involved? Front Biosci 9, 494-504 (2004a)
15. Roth J, E. M. Harre, C. Rummel, R. Gerstberger & T. Hubschle: Signaling the brain in systemic inflammation: role of sensory circumventricular organs. Front Biosci 9, 290-300 (2004a)
16. Roth J, E. Zeisberger, S. Vybíral & L. Janský: Endogenous antipyretics: neuropeptides and glucocorticoids. Front Biosci 9, 816-826 (2004b)
17. Székely M, E. Pétervári & Z. Szelényi: Orexigenic vs. anorexigenic peptides and feeding status in the modulation of fever and hypothermia. Front Biosci 9, 2746-2763 (2004)
18. Szelényi Z. & M. Székely: Sickness behavior in fever and hypothermia. Front Biosci 9, 2447-2456 (2004)
19. Szelényi Z, M. Székely, Z. Hummel, M. Balaskó, A. A. Romanovsky & E. Pétervári: Cholecystokinin: possible mediator of fever and hypothermia. Front Biosci 9, 301-308 (2004)
20. Watanabe T, M. Miyoshi & T. Imoto: Angiotensin II: its effects on fever and hypothermia in systemic inflammation. Front Biosci 9, 438-447 (2004)
21. Cabanac M. & B. Massonnet: [Pathology of thermoregulation.] Rev Neurol (Paris) 136, 285-302 (1980) (in French)
22. Kluger M. J: Fever: role of pyrogens and cryogens. Physiol Rev 71, 93-127 (1991)
23. The Commission for Thermal Physiology of the International Union of Physiological Sciences (IUPS Thermal Commission): Glossary of terms for thermal physiology: third edition. Jpn J Physiol 51, i-xxxvi, (2001)
24. Gordon C. J: The therapeutic potential of regulated hypothermia. Emerg Med J 18, 81-89 (2001)
25. Steiner A. A. & L. G. S. Branco: Hypoxia-induced anapyrexia: implications and putative mediators. Annu Rev Physiol 64, 263-288 (2002)
26. Satinoff E: Neural organization and evolution of thermal regulation in mammals. Science 201, 16-22 (1978)
27. Werner J: The concept of regulation for human body temperature. J Therm Biol 5, 75-82 (1979)
28. Nagashima K, S. Nakai, M. Tanaka, & K. Kanosue: Neuronal circuitries involved in thermoregulation. Anton Neurosci 85, 18-25 (2000)
29. Kanosue K, A. A. Romanovsky, T. Hosono, X.-M. Chen, and Y.-Z. Zhang: "Set point" revisited. In: Thermal Physiology 1997 (Eds: Nielsen Johannsen B. & R. Nielsen), The August Krogh Institute, Copenhagen, Denmark, pp. 39-43 (1997)
30. Romanovsky A. A, O. Shido, S. Sakurada, N. Sugimoto, & T. Nagasaka: Endotoxin shock: thermoregulatory mechanisms. Am J Physiol Regul Integr Comp Physiol 270, R693-R703 (1996)
31. Sessler D. I: Mild perioperative hypothermia. N Engl J Med 336, 1730-1737 (1997)
32. Kobayashi A, T. Osaka, Y. Namba, S. Inoue, T. H. Lee, & S. Kimura: Capsaicin activates heat loss and heat production simultaneously and independently in rats. Am J Physiol 275, R92-R98 (1998)
33. Sakurada S, O. Shido, N. Sugimoto, Y. Hiratsuka, T. Yoda, & K. Kanosue: Autonomic and behavioral thermoregulation in starved rats. J Physiol 526, 417-424 (2000)
34. Romanovsky A. A: Do fever and anapyrexia exist? Analysis of set point-based definitions. Am J Physiol Regul Integr Comp Physiol 287, R992-R995 (2004b)
35. Splawiński J. A, E. Zacny, & Z. Górka: Fever in rats after intravenous E. coli endotoxin administration. Pflügers Arch 368, 125-128 (1977)
36. Székely M. & Z. Szelényi: Endotoxin fever in the rat. Acta Physiol Acad Sci Hung 53, 265-277 (1979)
37. Romanovsky A. A, V. A. Kulchitsky, C. T. Simons & N. Sugimoto: Methodology of fever research: why are polyphasic fevers often thought to be biphasic? Am J Physiol Regul Integr Comp Physiol 275, R332-R338 (1998a)
38. Romanovsky A. A, A. I. Ivanov & Y. P. Shimansky: Selected contribution: ambient temperature for experiments in rats: a new method for determining the zone of thermal neutrality. J Appl Physiol 92, 2667-2679 (2002)
39. Elmquist J. K, T. E. Scammell, C. D. Jacobson & C. B. Saper: Distribution of Fos-like immunoreactivity in the rat brain following intravenous lipopolysaccharide administration. J Comp Neurol 371, 85-103 (1996)
40. Caldwell F. T. Jr, D. B. Graves & B. H. Wallace: Humoral versus neural pathways for fever production in rats after administration of lipopolysaccharide. J Trauma 47, 120-129 (1999)
41. Wachulec M, E. Peloso, E. Satinoff: Individual differences in response to LPS and psychological stress in aged rats. Am J Physiol Regul Integr Comp Physiol 272, R1252-R1257 (1997)
42. Chai Z, S. Gatti, C. Toniatti, V. Poli & T. Bartfai: Interleukin (IL)-6 gene expression in the central nervous system is necessary for fever response to lipopolysaccharide or IL-1beta: a study on IL-6-deficient mice. J Exp Med 183, 311-316 (1996)
43. Leon L. R, C. A. Conn, M. Glaccum & M. J. Kluger: IL-1 type I receptor mediates acute phase response to turpentine, but not lipopolysaccharide, in mice. Am J Physiol 271, R1668-R1675 (1996)
44. Horai R, M. Asano, K. Sudo, H. Kanuka, M. Suzuki, M. Nishihara, M. Takahashi & Y. Iwakura: Production of mice deficient in genes for interleukin (IL)-1alpha, IL-1beta, IL-1alpha/beta, and IL-1 receptor antagonist shows that IL-1beta is crucial in turpentine-induced fever development and glucocorticoid secretion. J Exp Med 187, 1463-1475 (1998)
45. Ushikubi F, E. Segi, Y. Sugimoto, T. Murata, T. Matsuoka, T. Kobayashi, H. Hizaki, K. Tuboi, M. Katsuyama, A. Ichikawa, T. Tanaka, N. Yoshida & S. Narumiya: Impaired febrile response in mice lacking the prostaglandin E receptor subtype EP3. Nature 395, 281-284 (1998)
46. Li S, Y. Wang, K. Matsumura, L. R. Ballou, S. G. Morham & C. M. Blatteis: The febrile response to lipopolysaccharide is blocked in cyclooxygenase-2(-/-), but not in cyclooxygenase-1(-/-) mice. Brain Res 825, 86-94 (1999)
47. Kozak W. & A. Kozak: Differential role of nitric oxide synthase isoforms in fever of different etiologies: studies using NOS gene-deficient mice. J Appl Physiol 94, 2534-2544 (2003)
48. Engblom D, S. Saha, L. Engstrom, M. Westman, L. P. Audoly, P. J. Jakobsson & A. Blomqvist: Microsomal prostaglandin E synthase-1 is the central switch during immune-induced pyresis. Nat Neurosci 6, 1137-1138 (2003)
49. Oka T, K. Oka, T. Kobayashi, Y. Sugimoto, A. Ichikawa, F. Ushikubi, S. Narumiya & C. B. Saper: Characteristics of thermoregulatory and febrile responses in mice deficient in prostaglandin EP1 and EP3 receptors. J Physiol 551, 945-954 (2003a)
50. Romanovsky A. A, C. T. Simons & V. A. Kulchitsky: "Diphasic" fevers often consist of more than two phases. Am J Physiol Regul Integr Comp Physiol 275, R323-R331 (1998b)
51. Romanovsky A. A: Thermoregulatory manifestations of systemic inflammation: lessons from vagotomy. Auton Neurosci 85, 39-48 (2000)
52. Romanovsky A. A, C. T. Simons, M. Székely & V. A. Kulchitsky: The vagus nerve in the thermoregulatory response to systemic inflammation. Am J Physiol Regul Integr Comp Physiol 213, R407-R413 (1997a)
53. Vybíral S, M. Székely, L. Janský, & L. Černý: Thermoregulation of the rabbit during the late phase of endotoxin fever. Pflügers Arch 410, 220-202 (1987)
54. Clemmer T. P, C. J. Fisher Jr, R. C. Bone, G. J. Slotman, C. A. Metz, F. O. Thomas, & The Methylprednisolone Severe Sepsis Study Group: Hypothermia in the sepsis syndrome and clinical outcome. Crit Care Med 20, 1395-1401 (1992)
55. Dogan M. D, H. Ataoglu & E. S. Akarsu: Effects of selective cyclooxygenase enzyme inhibitors on lipopolysaccharide-induced dual thermoregulatory changes in rats. Brain Res Bull 57, 179-185 (2002)
56. Giusti-Paiva A, M. De Castro, J. Antunes-Rodrigues & E. C. Carnio: Inducible nitric oxide synthase pathway in the central nervous system and vasopressin release during experimental septic shock. Crit Care Med 30, 1306-1310 (2002)
57. Zhang Y. H, J. Lu, J. K. Elmquist & C. B. Saper: Specific roles of cyclooxygenase-1 and cyclo-oxygenase-2 in lipopolysaccharide-induced fever and Fos expression in rat brain. J Comp Neurol 463, 3-12 (2003)
58. Azab A. N. & J. Kaplanski: Involvement of eicosanoids in the hypothermic response to lipopolysaccharide during endotoxemia in rats. Prostaglandins Leukot Essent Fatty Acids 70, 67-75 (2004)
59. Steiner A. A, M. D. Dogan, A. I. Ivanov, S. Patel, A. Y. Rudaya, D. H. Jennings, M. Orchinik, T. W. W. Pace, K. A. O'Connor, L. R. Watkins & A. A. Romanovsky: A new function of the leptin receptor: mediation of the recovery from lipopolysaccharide-induced hypothermia. FASEB J 18, 1949-1951 (2004)
60. Beutler B. & E. T. Rietschel: Innate immune sensing and its roots: the story of endotoxin. Nat Rev Immunol 3, 169-176 (2003)
61. Qureshi S. T. & R. Medzhitov: Toll-like receptors and their role in experimental models of microbial infection. Genes Immun 4, 87-94 (2003)
62. Poltorak A, X. He, I. Smirnova, M. Y. Liu, C. Van Huffel, X. Du, D. Birdwell, E. Alejos, M. Silva, C. Galanos, M. Freudenberg, P. Ricciardi-Castagnoli, B. Layton & B. Beutler: Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science 282, 2085-2088 (1998)
63. Nagai Y, S. Akashi, M. Nagafuku, M. Ogata, Y. Iwakura, S. Akira, T. Kitamura, A. Kosugi, M. Kimoto & K. Miyake: Essential role of MD-2 in LPS responsiveness and TLR4 distribution. Nat Immunol 3, 667-672 (2002)
64. Yang R. B, M. R Mark, A. Gray, A. Huang, M. H. Xie, M. Zhang, A. Goddard, W. I. Wood, A. L. Gurney & P. J. Godowski: Toll-like receptor-2 mediates lipopolysaccharide-induced cellular signaling. Nature 395, 284-288 (1998)
65. Dinarello C. A, S. Gatti & T. Bartfai: Fever: links with an ancient receptor. Curr Biol 9, R147-R150 (1999)
66. Hirschfeld M, Y. Ma, J. H. Weis, S. N. Vogel & J. J. Weis: Cutting edge: repurification of lipopolysaccharide eliminates signaling through both human and murine toll-like receptor 2. J Immunol 165, 618-622 (2000)
67. Lee H. K, J. Lee & P. S. Tobias: Two lipoproteins extracted from Escherichia coli K-12 LCD25 lipopolysaccharide are the major components responsible for Toll-like receptor 2-mediated signaling. J Immunol 168, 4012-4017 (2002)
68. Von Meyenburg C, B. H. Hrupka, D. Arsenijevic, G. J. Schwartz, R. Landmann & W. Langhans: Role for CD14, TLR2, and TLR4 in bacterial product-induced anorexia. Am J Physiol Regul Integr Comp Physiol 287, R298-R305 (2004)
69. Perera P. Y, T. N. Mayadas, O. Takeuchi, S. Akira, M. Zaks-Zilberman, S. M. Goyert & S. N.Vogel: CD11b/CD18 acts in concert with CD14 and Toll-like receptor (TLR) 4 to elicit full lipopolysaccharide and taxol-inducible gene expression. J Immunol 166, 574-581 (2001)
70. Pearson A. M: Scavenger receptors in innate immunity. Curr Opin Immunol 8, 20-28 (1996)
71. Gioannini T. L, A. Teghanemt, K. A. Zarember & J. P. Weiss: Regulation of interactions of endotoxin with host cells. J Endotoxin Res 9, 401-408 (2003)
72. Ivanov A. I, S. Patel, V. A. Kulchitsky & A. A. Romanovsky: Platelet-activating factor: a previously unrecognized mediator of fever. J Physiol 553, 221-228 (2003a)
73. Takeuchi O, K. Hoshino, T. Kawai, H. Sanjo, H. Takada, T. Ogawa, K. Takeda & S. Akira: Differential roles of TLR2 and TLR4 in recognition of gram-negative and gram-positive bacterial cell wall components. Immunity 11, 443-451 (1999)
74. Yoshimura A, E. Lien, R. R. Ingalls, E. Tuomanen, R. Dziarski & D. Golenbock: Cutting edge: recognition of Gram-positive bacterial cell wall components by the innate immune system occurs via Toll-like receptor 2. J Immunol 163, 1-5 (1999)
75. Janssens S. & R. Beyaert: Role of Toll-like receptors in pathogen recognition. Clin Microbiol Rev 16, 637-646 (2003)
76. Dinarello C. A: Infection, fever, and exogenous and endogenous pyrogens: some concepts have changed. J Endotoxin Res 10, 201-222 (2004)
77. Kelly J. F, C. F. Elias, C. E. Lee, R. S. Ahima, R. J. Seeley, C. Bjorbaek, T. Oka, C. B. Saper, J. S. Flier & J. K. Elmquist: Ciliary neurotrophic factor and leptin induce distinct patterns of immediate early gene expression in the brain. Diabetes 53, 911-920 (2004)
78. Roth J, D. Martin, B. Storr & E. Zeisberger: Neutralization of pyrogen-induced tumor necrosis factor by its type 1 soluble receptor in guinea pigs: effects on fever and interleukin-6 release. J Physiol 509, 267-275 (1998)
79. Netea M. G, B. J. Kullberg & J. W. Van der Meer: Circulating cytokines as mediators of fever. Clin Infect Dis 31, Suppl 5, S178-S184 (2000)
80. 1-acid glycoprotein. Am J Physiol Regul Integr Comp Physiol (December 2, 2004; doi:10.1152/ ajpregu.00514.2004).
81. Han S. J, H. M. Ko, J. H. Choi, K. H. Seo, H. S. Lee, E. K. Choi, I. W. Choi, H. K. Lee & S. Y. Im: Molecular mechanisms for lipopolysaccharide- induced biphasic activation of nuclear factor-kappa B (NF-kappa B). J Biol Chem 277, 44715-44721 (2002)
82. Marrache A. M, F. Gobeil Jr., S. G. Bernier, J. Stankova, M. Rola-Pleszczynski, S. Choufani, G. Bkaily, A. Bourdeau, M. G. Sirois, A. Vazquez-Tello, L. Fan, J. S. Joyal, J. G. Filep, D. R. Varma, A. Ribeiro-Da-Silva & S. Chemtob: Proinflammatory gene induction by platelet-activating factor mediated via its cognate nuclear receptor. J Immunol 169, 6474-6481 (2002)
83. Libert C, W. Van Molle, P. Brouckaert & W. Fiers: Alpha1-Antitrypsin inhibits the lethal response to TNF in mice. J Immunol 157, 5126-5129 (1996)
84. Ephgrave K, T. Kremer, K. Broadhurst & J. Cullen: The role of platelet-activating factor in conscious, normotensive endotoxemia. J Surg Res 68, 170-174 (1997)
85. Steiner A. A, A. Y. Rudaya, A. I. Ivanov & A. A. Romanovsky. Febrigenic signaling to the brain does not involve nitric oxide. Br J Pharmacol 141, 1204-1213 (2004)
86. Banks W. A, A. J. Kastin & D. A. Durham: Bidirectional transport of interleukin-1 alpha across the blood-brain barrier. Brain Res Bull 23, 433-437 (1989)
87. Banks W. A, S. A. Farr & J. E. Morley: Entry of blood-borne cytokines into the central nervous system: effects on cognitive processes. Neuroimmunomodulation 10, 319-327 (2002-2003)
88. Mercier F, J. T. Kitasako & G. I. Hatton: Fractones and other basal laminae in the hypothalamus. J Comp Neurol 455, 324-340 (2003)
89. Blatteis C. M, S. L. Bealer, W. S. Hunter, J. Llanos-Q, R. A. Ahokas & T. A. Mashbura Jr: Suppression of fever after lesions of the anteroventral third ventricle in guinea pigs. Brain Res Bull 11, 519-526 (1983)
90. Takahashi Y, P. Smith, A. Ferguson & Q. J. Pittman: Circumventricular organs and fever. Am J Physiol Regul Integr Comp Physiol 273, R1690-R1695 (1997)
91. Sehic E, R. Gerstberger & C. M. Blatteis: The effect of intravenous lipopolysaccharide on NADPH-diaphorase stainning (= nitric oxide synthase activity) in the organum vasculosum laminae terminalis of guinea pigs. Ann N Y Acad Sci 813, 383-391 (1997)
92. Cartmell T, G. N. Luheshi & N. J. Rothwell: Brain sites of action of endogenous interleukin-1 in the febrile response to localized inflammation in the rat. J Physiol 518, 585-594 (1999)
93. Romanovsky A. A, N. Sugimoto, C. T. Simons & W. S. Hunter. The organum vasculosum laminae terminalis (OVLT) in immune-to-brain febrigenic signaling: a reappraisal of lesion experiments. Am J Physiol Regul Integr Comp Physiol 285, R420-R428 (2003)
94. Stitt J. T. & S. G. Shimada: Site of action of calcium channel blockers in inhibiting endogenous pyrogen fever in rats. J Appl Physiol 71, 956-960 (1991)
95. Scammell T. E, J. K. Elmquist, J. D. Griffin & C. B. Saper: Ventromedial preoptic prostaglandin E2 activates fever-producing autonomic pathways. J Neurosci 16, 6246-6254 (1996)
96. Scammell T. E, J. D. Griffin, J. K. Elmquist & C. B. Saper: Microinjection of a cyclooxygenase inhibitor into the anteroventral preoptic region attenuates LPS fever. Am J Physiol Regul Integr Comp Physiol 274, R783-R789 (1998)
97. Lin M. T. & J. H. Lin: Involvement of tyrosine kinase in the pyrogenic fever exerted by NOS pathways in organum vasculosum laminae terminalis. Neuropharmacology 39, 347-352 (2000)
98. Morimoto A, N. Murakami, T. Nakamori & T. Watanabe: Evidence for separate mechanisms of induction of biphasic fever inside and outside the blood-brain barrier in rabbits. J Physiol 383, 629-637 (1987)
99. Cooper A. L. & N. J. Rothwell: Mechanisms of early and late hypermetabolism and fever after localized tissue injury in rats. Am J Physiol Endocrinol Metab 261, E698-E705 (1991)
100. Watkins L. R, L. E. Goehler, J. K. Relton, N. Tartaglia, L. Silbert, D. Martin & S. F. Maier: Blockade of interleukin-1 induced hyperthermia by subdiaphragmatic vagotomy: evidence for vagal mediation of immune-brain communication. Neurosci Lett 183, 27-31 (1995)
101. Székely M, M. Balaskó & A. A. Romanovsky: Capsaicin-sensitive neural afferents in fever pathogenesis (Abstract). Pflügers Arch 440, R64 (1995)
102. Romanovsky A. A, V. A. Kulchitsky, C. T. Simons, N. Sugimoto & M. Székely: Febrile responsiveness of vagotomized rats is suppressed even in the absence of malnutrition. Am J Physiol Regul Integr Comp Physiol 273, R777-R783 (1997b)
103. Romanovsky A. A, V. A. Kulchitsky, C. T. Simons, N. Sugimoto & M. Székely: Cold defense mechanisms in vagotomized rats. Am J Physiol 273, R784-R789 (1997c)
104. 2 and cholecystokinin octapeptide. Brain Res 844, 157-163 (1999)
105. Hansen M. K, S. Daniels, L. E. Goehler, R. P. Gaykema, S. F. Maier & L. R. Watkins: Subdiaphragmatic vagotomy does not block intraperitoneal lipopolysaccharide-induced fever. Auton Neurosci 85, 83-87 (2000)
106. Luheshi G. N, R. M. Bluthe, D. Rushforth, N. Mulcahy, J. P. Konsman, M. Goldbach & R. Dantzer: Vagotomy attenuates the behavioural but not the pyrogenic effects of interleukin-1 in rats. Auton Neurosci 85, 127-132 (2000)
107. Székely M, M. Balaskó, V. A. Kulchitsky, C. T. Simons, A. I. Ivanov & A. A. Romanovsky: Multiple neural mechanisms of fever. Auton Neurosci 85, 78-82 (2000)
108. Dogan M. D, S. Patel, A. Y. Rudaya, A. A. Steiner, M. Székely & A. A. Romanovsky: Lipopolysaccharide fever is initiated via a capsaicin-sensitive mechanism independent of the subtype-1 vanilloid receptor. Br J Pharmacol 143, 1023-1032 (2004)
109. Dogan M. D, V. A. Kulchitsky, S. Patel, E. Petervari, M. Szekely & A. A. Romanovsky: Bilateral splanchnicotomy does not affect lipopolysaccharide- induced fever in rats. Brain Res 993, 227-229 (2003)
110. Simons C. T, V. A. Kulchitsky, N. Sugimoto, L. D. Homer, M. Székely & A. A. Romanovsky: Signaling the brain in systemic inflammation: which vagal branch is involved in fever genesis? Am J Physiol Regul Integr Comp Physiol 275, R63-R68 (1998)
111. Mathison J. C. & R. J. Ulevitch: The clearance, tissue distribution, and cellular localization of intravenously injected lipopolysaccharide in rabbits. J Immunol 123, 2133-2143 (1979)
112. Ruiter D. J, J. van der Meulen, A. Brouwer, M. J. Hummel, B. J. Mauw, J. C. van der Ploeg & E. Wisse: Uptake by liver cells of endotoxin following its intravenous injection. Lab Invest 45, 38-45 (1981)
113. Dinarello C. A, P. T. Bodel & E. Atkins: The role of the liver in the production of fever and in pyrogenic tolerance. Trans Assoc Am Physicians 81, 334-344 (1968)
114. Li Z. & C. M. Blatteis: Fever onset is linked to the appearance of lipopolysaccharide in the liver. J Endotoxin Res 10, 39-53 (2004)
115. 2-synthesizing enzymes in fever: differential transcriptional regulation. Am J Physiol Regul Integr Comp Physiol 283, R1104-R1117 (2002)
116. Niijima A: The afferent discharges from sensors for interleukin-1beta in the hepatoportal system in the anesthetized rat. J Auton Nerv Syst 61, 287-291 (1996)
117. Goehler L. E, J. Relton, D. Dripps, R. Kiechle, N. Tartaglia, S. F. Maier & L. R. Watkins: Vagal paraganglia bind biotinylated interleukin-1 receptor antagonist: a possible mechanism for immune-to-brain communication. Brain Res Bull 43, 357-364 (1997)
118. Ek M, M. Kurosawa, T. Lundeberg, M. Heilig & A. Ericsson: Activation of vagal afferents after intravenous injection of interleukin-1beta: role of endogenous prostaglandins. J Neurosci 18, 9471-9479 (1998)
119. Hansen M. K, K. A. O'Connor, L. E. Goehler, L. R. Watkins & S. F. Maier: The contribution of the vagus nerve in interleukin-1beta-induced fever is dependent on dose. Am J Physiol Regul Integr Comp Physiol 280, R929-R934 (2001)
120. Yamagata K, K. Matsumura, W. Inoue, T. Shiraki, K. Suzuki, S. Yasuda, H. Sugiura, C. Cao, Y. Watanabe & S. Kobayashi: Coexpression of microsomal-type prostaglandin E synthase with cyclooxygenase-2 in brain endothelial cells of rats during endotoxin-induced fever. J Neurosci 21, 2669-2677 (2001)
121. Ek M, D. Engblom, S. Saha, A. Blomqvist, P. J. Jakobsson & A. Ericsson-Dahlstrand: Inflammatory response: pathway across the blood-brain barrier. Nature 410, 430-431 (2001)
122. Rivest S: What is the cellular source of prostaglandins in the brain in response to systemic inflammation? Facts and controversies. Mol Psychiatry 4, 500-507 (1999)
123. Cao C, K. Matsumura, K. Yamagata & Y. Watanabe: Endothelial cells of the rat brain vasculature express cyclooxygenase-2 mRNA in response to systemic interleukin-1 beta: a possible site of postaglandin synthesis responsible for fever. Brain Res 733, 263-272 (1996)
124. Matsumura K, C. Cao, M. Ozaki, H. Morii, K. Nakadate & Y. Watanabe: Brain endothelial cells express cyclooxygenase-2 during lipopolysaccharide- induced fever: light and electron microscopic immunocytochemical studies. J Neurosci 18, 6279-6289 (1998)
125. Elmquist J. K, C. D. Breder, J. E. Sherin, T. E. Scammell, W. F. Hickey, D. Dewitt & C. B. Saper: Intravenous lipopolysaccharide induces cyclooxygenase 2-like immunoreactivity in rat brain perivascular microglia and meningeal macrophages. J Comp Neurol 381, 119-129 (1997)
126. Schiltz J. C. & P. E. Sawchenko: Distinct brain vascular cell types manifest inducible cyclooxygenase expression as a function of the strength and nature of immune insults. J Neurosci 22, 5606-5618 (2002)
127. Konsman J. P, S. Vigues, L. Mackerlova, A. Bristow & A. Blomqvist: Rat brain vascular distribution of interleukin-1 type-1 receptor immunoreactivity: relationship to patterns of inducible cyclooxygenase expression by peripheral inflammatory stimuli. J Comp Neurol 472, 113-129 (2004)
128. 1 as a modulator for temperature regulation in the central nervous system of the cat. J Physiol 207, 76P-77P (1970)
129. Vane J. R: Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs. Nature 231, 232-235 (1971)
130. Tegeder I, J. Pfeilschifter & G. Geisslinger: Cyclooxygenase- independent actions of cyclooxygenase inhibitors. FASEB J 15, 2057-2072 (2001)
131. Yin M. J, Y. Yamamoto & R. B. Gaynor: The anti-inflammatory agents aspirin and salicylate inhibit the activity of I(kappa)B kinase-beta. Nature 396, 77-80 (1998)
132. Daun J. M, R. W. Ball, H. R. Burger & J. G. Cannon: Aspirin-induced increases in soluble IL-1 receptor type II concentrations in vitro and in vivo. J Leukoc Biol 65, 863-866 (1999)
133. 4-mediated induction of nitric oxide explains how aspirin inhibits acute inflammation. J Exp Med 200, 69-78 (2004)
134. 2 in the hypothermia of rats caused by bacterial lipopolysaccharide. Proc Natl Acad Sci USA 79, 6093-6097 (1982)
135. Derijk R. H, M. Van Kampen, N. Van Rooijen & F. Berkenbosch: Hypothermia to endotoxin involves reduced thermogenesis, macrophage-dependent mechanisms, and prostaglandins. Am J Physiol 266, R1-R8 (1994)
136. Gilroy D. W, P. R. Colville-Nash, D. Willis, J. Chivers, M. J. Paul-Clark & D. A. Willoughby: Inducible cyclooxygenase may have anti-inflammatory properties. Nat Med 5, 698-701 (1999)
137. 2 in the rat brain. J Neurosci 24, 1312-1318 (2004)
138. 2-biosynthetic pathway. Prog Lipid Res 43, 3-35 (2004)
139. Piper P. J, J. R. Vane & J. H. Wyllie: Inactivation of prostaglandins by the lungs. Nature 225, 600-604 (1970)
140. 2 by prostaglandin dehydrogenase is essential for remodeling the ductus arteriosus. Nat Med 8, 91-92 (2002)
141. 2 in lipopolysaccharide fever. Am J Physiol Regul Integr Comp Physiol 284, R698-R706 (2003b)
142. 2 entry into the brain. Pflügers Arch 442, 526-533 (2001)
143. Nakamura K, T. Kaneko, Y. Yamashita, H. Hasegawa, H. Katoh, A. Ichikawa & M. Negishi: Immunocytochemical localization of prostaglandin EP3 receptor in the rat hypothalamus. Neurosci Lett 260, 117-120 (1999)
144. Yoshida K, K. Nakamura, K. Matsumura, K. Kanosue, M. Konig, H. J. Thiel, Z. Boldogkoi, I. Toth, J. Roth, R. Gerstberger & T. Hubschle: Neurons of the rat preoptic area and the raphe pallidus nucleus innervating the brown adipose tissue express the prostaglandin E receptor subtype EP3. Eur J Neurosci 18, 1848-1860 (2003)
145. Nakamura K, K. Matsumura, T. Kaneko, S. Kobayashi, H. Katoh & M. Negishi: The rostral raphe pallidus nucleus mediates pyrogenic transmission from the preoptic area. J Neurosci 22, 4600-4610 (2002)
146. Morrison S. F, A. F. Sved & A. M. Passerin: GABA-mediated inhibition of raphe pallidus neurons regulates sympathetic outflow to brown adipose tissue. Am J Physiol 276, R290-R297 (1999)
147. 2-evoked increases in brown adipose tissue thermogenesis. Neuroscience 121, 17-24 (2003)
148. Rathner J. A. & R. M. McAllen: Differential control of sympathetic drive to the rat tail artery and kidney by medullary premotor cell groups. Brain Res 834, 196-199 (1999)
149. Tanaka M, K. Nagashima, R. M. McAllen & K. Kanosue: Role of the medullary raphé in thermoregulatory vasomotor control in rats. J Physiol 540, 657-664 (2002)
150. Hatae N, Y. Sugimoto & A. Ichikawa: Prostaglandin receptors: advances in the study of EP3 receptor signaling. J Biochem 131, 781-784 (2002)
151. Nakamura K: Fever-inducing sympathetic neural pathways. J Therm Biol 29, 339-344 (2004)
152. Oka T, K. Oka & C. B. Saper: Contrasting effects of E type prostaglandin (EP) receptor agonists on core body temperature in rats. Brain Res 968, 256-262 (2003b)
153. Bligh J: Temperature regulation: a theoretical consideration incorporating Sherringtonian principles of central neurology. J Therm Biol 9, 3-6 (1984)
154. Zhang Y. H, M. Yanase-Fujiwara, T. Hosono & K. Kanosue: Warm and cold signals from the preoptic area: which contribute more to the control of shivering in rats? J Physiol 485, 195-202 (1995)
155. Chen X. -M, T. Hosono, T. Yoda, Y. Fukuda & K. Kanosue: Efferent projection from the preoptic area for the control of non-shivering thermogenesis in rats. J Physiol 512, 883-892 (1998)
156. Griffin J. D, C. B. Saper & J. A. Boulant: Synaptic and morphological characteristics of temperature-sensitive and -insensitive rat hypothalamic neurons. J Physiol 537, 521-535 (2001)
157. Cliffer K. D, R. Burstein & G. J. Giesler Jr: Distributions of spinothalamic, spinohypothalamic, and spinotelencephalic fibers revealed by anterograde transport of PHA-L in rats. J Neurosci 11, 852-868 (1991)
158. Morrison S. F: Central pathways controlling brown adipose tissue thermogenesis. News Physiol Sci 19, 67-74 (2004)
159. Bamshad M, C. K. Song & T. J. Bartness: CNS origins of the sympathetic nervous system outflow to brown adipose tissue. Am J Physiol 276, R1569-R1578 (1999)
160. Oldfield B. J, M. E. Giles, A. Watson, C. Anderson, L. M. Colvill & M. J. McKinley: The neurochemical characterization of hypothalamic pathways projecting polysynaptically to brown adipose tissue in the rat. Neuroscience 110, 515-526 (2002)
161. Cano G, A. M. Passerin, J. C. Schiltz, J. P. Card, S. F. Morrison & A. F. Sved: Anatomical substrates for the central control of sympathetic outflow to interscapular adipose tissue during cold exposure. J Comp Neurol 460, 303-326 (2003)
162. McAllen R. M: Preoptic thermoregulatory mechanisms in detail. Am J Physiol Regul Integr Comp Physiol 287, R272-R273 (2004)
163. Horn T, M. F. Wilkinson, R. Landgraf & Q. J. Pittman: Reduced febrile responses to pyrogens after lesions of the hypothalamic paraventricular nucleus. Am J Physiol 267, R323-R328 (1994)
164. Almeida M. C, A. A. Steiner, N. C. Coimbra & L. G. S. Branco: Thermoeffector neuronal pathways in fever: a study in rats showing a new role of the locus coeruleus. J Physiol 558, 283-294 (2004)
165. Sugimoto N, O. Shido, S. Sakurada & T. Nagasaka: Day-night variations
166. Florez-Duquet M, E. Peloso, E. Satinoff: Fever and behavioral thermoregulation in young and old rats. Am J Physiol 280, R1457-R1461 (2001)
167. Turek V. F, D. H. Olster, A. Ettenberg & H. J. Carlisle: The behavioral thermoregulatory response of febrile female rats is not attenuated by vagotomy. Pharmacol Biochem Behav 80, 115-121 (2005)
168. Maruyama M, M. Nishi, M. Konishi, Y. Takashige, K. Nagashima, T. Kiyohara & K. Kanosue: Brain regions expressing Fos during thermoregulatory behavior in rats. Am J Physiol Regul Integr Comp Physiol 285, R1116-R1123 (2003)
169. Grunfeld C, C. Zhao, J. Fuller, A. Pollack, A. Moser, J. Friedman & K. R. Feingold: Endotoxin and cytokines induce expression of leptin, the ob gene product, in hamsters. J Clin Invest 97, 2152-2157 (1996)
170. Janik J. E, B. D. Curti, R. V. Considine, H. C. Rager, G. C. Powers, W. G. Alvord, J. W. Smith II, B. L. Gause & W. C. Kopp: Interleukin-1 alpha increases serum leptin concentrations in humans. J Clin Endocrinol Metab 82, 3084-3086 (1997)
171. Sarraf P, R. C. Frederich, E. M. Turner, G. Ma, N. T. Jaskowiak, D. J. Rivet III, J. S. Flier, B. B. Lowell, D. L. Fraker & H. R. Alexander: Multiple cytokines and acute inflammation raise mouse leptin levels: potential role in inflammatory anorexia. J Exp Med 185, 171-175 (1997)
172. Loffreda S, S. Q. Yang, H. A. Lin, C. L. Karp, M. L. Brengman, D. J. Wang, A. S. Klein, G. B. Bulkely, C. Bao, P. W. Noble, M. D. Lane & A. M. Diehl: Leptin regulates proinflammatory immune response. FASEB J 12, 57-65 (1998)
173. Lord G. M, G. Matarese, J. K. Howard, R. J. Baker, S. R. Bloom & R. I. Lechler: Leptin modulates T-cell immune response and reverses starvation-induced immunosuppression. Nature 394, 897-901 (1998)
174. Scarpace P. J, M. Nicolson & M. Matheny: UCP2, UCP3 and leptin gene expression: Modulation by food restriction and leptin. J Endocrinol 159, 349-357 (1998)
175. Pelleymounter M. A, M. J. Cullen, M. B. Baker, R. Hechy, D. Winters, T. Boone & F. Collins: Effects of the obese gene product on body weight regulation in ob/ob mice. Science 269, 540-543 (1995)
176. Haynes W. G, D. A. Morgan, S. A. Walsh, A. L. Mark & W. I. Sivitz: Receptor-mediated regional sympathetic nerve activation by leptin. J Clin Invest 100, 270-278 (1997)
177. Luheshi G. N, J. D. Gardner, D. A. Rushforth, A. S. Loudon & N. J. Rothwell: Leptin actions on food intake and body temperature are mediated by IL-1. Proc Natl Acad Sci, USA 96, 7047-7052 (1999)
178. Turek V. F, D. H. Olster, K. R. Gililland, M. Sheehy, A. Ettenberg & H. J. Carlisle: The effects of melanocortin agonists and antagonists on leptin-induced fever in rats. J Therm Biol 29, 423-430 (2004)
179. Ivanov, A. I. & A. A. Romanovsky: Fever responses of Zucker rats with and without fatty mutation of the leptin receptor. Am J Physiol Regul Integr Comp Physiol 282, R311-R316 (2002)
180. Dascombe M. J, A. Hardwick, R. A. Lefeuvre & N. J. Rothwell: Impaired effects of interleukin-1 beta on fever and thermogenesis in genetically obese rats. Int J Obes 13, 367-373 (1989)
181. Jászberényi M, E. Bujdosó, E. Kiss, I. Pataki & G. Telegdy: The role of NPY in the mediation of orexin-induced hypothermia. Regul Pept 104, 55-59 (2002)
182. Székely M, E. Pétervári, M. Balaskó, I. Hernándi & B. Uzsoki: Effects of orexins on energy balance and thermoregulation. Regul Pept 104, 47-53 (2002)
183. Monda M, A. Viggiano & V. De Luca: Paradoxical effect of orexin A: hypophagia induced by hyperthermia. Brain Res 961, 220-228 (2003)
184. Balaskó M, Z. Szelényi & M. Székely: Central thermoregulatory effects of neuropeptide Y and orexin A in rats. Acta Physiol Hung 86, 219-222 (1999)
185. McMahon C. D, D. F. Buxton, T. H. Elsasser, D. R. Gunter, L. G. Sanders, B. P. Steele & J. L. Sartin: Neuropeptide Y restores appetite and alters concentrations of GH after central administration to endotoxic sheep. J Endocrinol 161, 333-339 (1999)
186. Linthorst A. C, C. Flachskamm, S. J. Hopkins, M. S. Hoadley, M. S. Labeur, F. Holsboer & J. M. Reul: Long term intracerebroventricular infusion of corticotropin-releasing hormone alters neuroendocrine, neurochemical, autonomic, behavioral, and cytokine responses to a systemic inflammatory challenge. J Neurosci 17, 4448-4460 (1997)
187. Drolet G. & S. Rivest: Corticotropin-releasing hormone and its receptors; an evaluation at the transcription level in vivo. Peptides 22, 761-767 (2001)
188. Turnbull A. V. & C. L. Rivier: Regulation of the hypothalamic- pituitary-adrenal axis by cytokines: actions and mechanisms of action. Physiol Rev 79, 1-71 (1999)
189. Coelho M. M, G. E. Souza & I. R. Pela: Endotoxin-induced fever is modulated by endogenous glucocorticoids in rats. Am J Physiol 263, R423-R427 (1992)
190. De Fanti B. A. & J. A. Martinez: Central urocortin activation of sympathetic-regulated energy metabolism in Wistar rats. Brain Res 930, 37-41 (2002)
191. Asakawa A, A. Inui, N. Ueno, S. Makino, M. Fujimiya, M. A. Fujino & M. Kasuga: Urocortin reduces oxygen consumption in lean and ob/ob mice. Int J Mol Med 7: 539-541 (2001)
192. Bachtell R. K, A. Z. Weitemier & A. E. Ryabinin: Lesions of the Edinger-Westphal nucleus in C57BL/6J mice disrupt ethanol-induced hypothermia and ethanol consumption. Eur J Neurosci 20, 1613-1623 (2004)
193. Shimuzu H, M. Miyoshi, K. Matsumoto, O. Goto, T. Imoto & T. Watanabe: The effect of central injection of angiotensin-converting enzyme inhibitor and the angiotensin type 1 receptor antagonist on the induction by lipopolysaccharide of fever and brain interleukin-1beta response in rats. J Pharmacol Exp Ther 308, 865-73 (2004)
194. Szelényi Z, L. Barthó, M. Székely & A. A. Romanovsky: Cholecystokinin octapeptide (CCK-8) injected into a cerebral ventricle induces a fever-like thermoregulatory response mediated by type B CCK-receptors in the rat. Brain Res 638, 69-77 (1994)
195. Székely M, Z. Szelényi & M. Balaskó: Cholecystokinin participates in the mediation of fever. Pflügers Arch 428, 671-673 (1994)
196. Martin S. M, B. C. Wilson, X. Chen, Y. Takahashi, P. Poulin & Q. J. Pittman: Vagal CCK and 5-HT(3) receptors are unlikely to mediate LPS or IL-1 beta-induced fever. Am J Physiol Regul Integr Comp Physiol 279, R960-R965 (2000)
197. Ivanov A. I, V. A. Kulchitsky & A. A. Romanovsky: Role for the cholecystokinin-A receptor in fever: a study of a mutant rat strain and a pharmacological analysis. J Physiol 547, 941-949 (2003c)
198. Huang Q. H, V. J. Hruby & J. B. Tatro: Systemic alpha-MSH suppresses LPS fever via central melanocortin receptors independently of its suppression of corticosterone and IL-6 release. Am J Physiol Regul Integr Comp Physiol 44, R524-R530 (1998)
199. Huang Q. H, V. J. Hruby & J. B. Tatro: Role of central melanocortins in endotoxin-induced anorexia. Am J Physiol Regul Integr Comp Physiol 45, R864-R871 (1999)
200. Sinha P. S, H. B. Schioth & J. B. Tatro: Activation of central melanocortin-4 receptors suppresses lipopolysaccharide-induced fever in rats. Am J Physiol Regul Integr Comp Physiol 284, R1595-R1603 (2003)
201. Pittman Q. J & M. F. Wilkinson: Central arginine vasopressin and endogenous antipyresis. Can J Physiol Pharmacol 70, 786-790 (1992).
202. Romanovsky A. A, A. A. Steiner, L. G. S. Branco, L. Jansky & V. N. Gourine: Arginine vasopressin in fever: a still unsolved puzzle. J Therm Biol 29, 407-412 (2004)
203. Bernardini, G. L, J. M. Lipton & W. G. Clark: Intracerebroventricular and septal injections of arginine vasopressin are not antipyretic in the rabbit. Peptides 4, 195-198 (1983)
204. 1a-R expression in the rat hypothalamus around parturition: relevance to antipyresis at term. Exp Neurol 183, 338-345 (2003)
205. 2. Am J Physiol Regul Integr Comp Physiol 283, R1346-R1353 (2002)
206. 2? Am J Physiol Regul Integr Comp Physiol 284, R860-R861 (2003)
207. Fofie A. E & J. E. Fewell: Influence of pregnancy on plasma cytokines and the febrile response to intraperitoneal administration of bacterial endotoxin in rats. Exp Physiol 88, 747-754 (2003)
208. Romanovsky A. A. & M. Székely: Fever and hypothermia: two adaptive thermoregulatory responses to systemic inflammation. Med Hypotheses 50, 219-226 (1998)
209. Aronoff D. M. & E. G. Neilson: Antipyretics: mechanisms of action and clinical use in fever suppression. Am J Med 111, 304-315 (2001)
210. Diringer M. N, N. L. Reaven, S. E. Funk & G. C. Uman: Elevated body temperature independently contributes to increased length of stay in neurologic intensive care unit patients. Crit Care Med 32, 1489-1495 (2004)
211. Zaremba J: Hyperthermia in ischemic stroke. Med Sci Monit 10, RA148-RA153 (2004)
212. Xie W. L, J. G. Chipman, D. L. Robertson, R. L. Erikson & D. L. Simmons: Expression of a mitogen-responsive gene encoding prostaglandin synthase is regulated by mRNA splicing. Proc Natl Acad Sci USA 88, 2692-2696 (1991)
213. Kujubu D. A, B. S. Fletcher, B. C. Varnum, R. W. Lim & H. R. Herschman: TIS10, a phorbol ester tumor promoter-inducible mRNA from Swiss 3T3 cells, encodes a novel prostaglandin synthase/cyclooxygenase homologue. J Biol Chem 266, 12866-12872 (1991)
214. O'Banion M. K, H. B. Sadowski, V. Winn & D. A. Young: A serum- and glucocorticoid-regulated 4-kilobase mRNA encodes a cyclooxygenase-related protein. J Biol Chem 266, 23261-23267 (1991)
215. Mitchell J. A, P. Akarasereenont, C. Thiemermann, R. J. Flower & J. R. Vane: Selectivity of nonsteroidal anti-inflammatory drugs as inhibitors of constitutive and inducible cyclooxygenase. Proc Natl Acad Sci USA 90, 11693-11697 (1994)
216. Futaki N, S. Takahashi, M. Yokoyama, I. Arai, S. Higuchi & S. Otomo: NS-398, a new anti-inflammatory agent, selectively inhibits prostaglandin G/H synthase/cyclooxygenase (COX-2) activity in vitro. Prostaglandins 47, 55-59 (1994)
217. Copeland R. A, J. M. Williams, J. Giannaras, S. Nurnberg, M. Covington, D. Pinto, S. Pick & J. M. Trzaskos: Mechanism of selective inhibition of the inducible isoform of prostaglandin G/H synthase. Proc Natl Acad Sci USA 91, 11202-11206 (1994)
218. Gans K. R, W. Galbraith, R. J. Roman, S. B. Haber, J. S. Kerr, W. K. Schmidt, C. Smith, W. E. Hewes & N. R. Ackerman: Anti-inflammatory and safety profile of DuP 697, a novel orally effective prostaglandin synthesis inhibitor. J Pharmacol Exp Ther 254, 180-187 (1990)
219. Futaki N, K. Yoshikawa, Y. Hamasaka, I. Arai, S. Higuchi, H. Iizuka & S. Otomo: NS-398, a novel non-steroidal anti-inflammatory drug with potent analgesic and antipyretic effects, which causes minimal stomach lesions. Gen Pharmacol 24, 105-110 (1993)
220. Riendeau D, M. D. Percival, C. Brideau, S. Charleson, D. Dube, D. Ethier, J. P. Falgueyret, R. W. Friesen, R. Gordon, G. Greig, J. Guay, J. Mancini, M. Ouellet, E. Wong, L. Xu, S. Boyce, D. Visco, Y. Girard, P. Prasit, R. Zamboni, I. W. Rodger, M. Gresser, A. W. Ford-Hutchinson, R. N. Young & C. C. Chan: Etoricoxib (MK-0663): preclinical profile and comparison with other agents that selectively inhibit cyclooxygenase-2. J Pharmacol Exp Ther 296, 558-566 (2001)
221. Tacconelli S, M. L. Capone, M. G. Sciulli, E. Ricciotti & P. Patrignani: The biochemical selectivity of novel COX-2 inhibitors in whole blood assays of COX-isozyme activity. Curr Med Res Opin 18, 503-511 (2002)
222. Crofford L. J: Specific cyclooxygenase-2 inhibitors: what have we learned since they came into widespread clinical use? Curr Opin Rheumatol 14, 225-230 (2002)
223. Solomon D. H, S. Schneeweiss, R. J. Glynn, Y. Kiyota, R. Levin, H. Mogun & J. Avorn. Relationship between selective cyclooxygenase-2 inhibitors and acute myocardial infarction in older adults. Circulation 109, 2068-2073 (2004)
224. 2 synthases. Proc Natl Acad Sci USA 99, 7130-7135 (2002)
225. Flower R. J. & J. R. Vane: Inhibition of prostaglandin synthetase in brain explains the anti-pyretic activity of paracetamol (4-acetamidophenol). Nature 240, 410-411 (1972)
226. Botting R. M: Mechanism of action of acetaminophen: is there a cyclooxygenase 3? Clin Infect Dis 31, Suppl 5, S202-S210 (2000)
227. Chandrasekharan N. V, H. Dai, K. L. Roos, N. K. Evanson, J. Tomsik, T. S. Elton & D. L. Simmons: COX-3, a cyclooxygenase-1 variant inhibited by acetaminophen and other analgesic/antipyretic drugs: cloning, structure, and expression. Proc Natl Acad Sci USA 99, 13926-13931 (2002)
228. Davies N. M, R. L. Good, K. A. Roupe & J. A. Yanez: Cyclooxygenase-3: axiom, dogma, anomaly, enigma or splice error? - not as easy as 1, 2, 3. J Pharm Pharmaceut Sci 7, 217-226 (2004)
229. Dou W, Y. Jiao, S. Goorha, R. Raghow & L. R. Ballou: Nociception and the differential expression of cyclooxygenase-1 (COX-1), the COX-1 variant retaining intron-1 (COX-1v), and COX-2 in mouse dorsal root ganglia (DRG). Prostaglandins Other Lipid Mediat 74, 29-43 (2004)
230. Snipes J. A, B. Kis, G. S. Shelness, J. A. Hewett & D. W. Busija: Cloning and characterization of cyclooxygenase-1b (putative COX-3) in rat. J Pharmacol Exp Ther DOI:10.1124/jpet.104.079533 (2005)
231. Shaftel S. S, J. A. Olschowka, S. D. Hurley, A. H. Moore & M. K. O'Banion: COX-3: a splice variant of cyclooxygenase-1 in mouse neural tissue and cells. Brain Res Mol Brain Res 119, 213-215 (2003); Erratum in: Brain Res Mol Brain Res 123, 1362004 (2004)
232. Dinchuk J. E, R. Q. Liu & J. M. Trzaskos: COX-3: in the wrong frame in mind. Immunol Lett 86, 121 (2003)
233. Kis B, J. A. Snipes, T. Isse, K. Nagy & D. W. Busija: Putative cyclooxygenase-3 expression in rat brain cells. J Cereb Blood Flow Metab 23, 1287-1292 (2003)
234. 2: investigating the activities of acetaminophen and cyclooxygenase-2-selective inhibitors in rat tissues. J Pharmacol Exp Ther 310, 642-647 (2004)
235. Cui J. G, H. Kuroda, N. V. Chandrasekharan, R. P. Pelaez, D. L. Simmons, N. G. Bazan & W. J. Lukiw: Cyclooxygenase-3 gene expression in Alzheimer hippocampus and in stressed human neural cells. Neurochem Res 29, 1731-1737 (2004)